Salvarx Share Discussion Threads

[castleford tiger] 14/3/2022 21:03

What’s the connection with ASBE please

[the stigologist] 14/10/2021 14:41

Talk a good game but never deliver

[abadan2] 25/6/2021 15:29

I am a big holder of Portage via SALV. While I enjoyed seeing the Portage share price in the high $30s, I was aware that there had been no specific news that could necessarily support that price. A fund raising of $23m at $23 tells us that the serious investors who put up the money see meaningful upside from this level, which should be good news for the price once the dust settles.

[abadan2] 25/6/2021 15:23

I am a big holder of Portage via SALV. While I enjoyed seeing the POit was

[bscuit] 23/6/2021 23:49

US Placing underway

[the stigologist] 23/6/2021 22:34

PRTG announce offering after close

Stock down 25% in After Hours trading

Get it out the way it'll do fine I'm sure

[abadan2] 22/6/2021 08:16

Testing to see if this thread is still operating!

[bscuit] 02/3/2021 22:34

I have asked AJB to arrange for mine to be able to be traded there and apparently I was far from the first to ask.

[mellonsbellend] 02/3/2021 18:50

I was hoping to have my useless CSE Portage shares converted to Nasdaq. Wishful thinking

[bscuit] 25/2/2021 16:05

received 1530 UK

PORTAGE BIOTECH INC.

NEWS RELEASE

PORTAGE COMMENCES TRADING ON NASDAQ
- Trading of ordinary shares begins under the symbol “PRTG” –

Toronto, ON – (February 25, 2021) – Portage Biotech Inc. (CSE: PBT.U,) (NASDAQ:PRTG) (“Portage̶1; or the “Company”;) a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the commencement of trading of its ordinary shares on the NASDAQ Capital Market (“Nasdaq”;) under the symbol “PRTG.” The Company’s ordinary shares will continue to trade on the Canadian Securities Exchange (CSE).

As one of the largest exchanges in the world, listing on Nasdaq is considered a significant corporate milestone. Companies listed are obligated to meet and uphold stringent corporate governance, equity and market value requirements.

“Listing on the Nasdaq is an important step for Portage, one that we believe will increase our visibility in the marketplace, provide opportunities for institutional investors and enhance our ability to broaden our investor base,” said Dr. Ian Walters, chief executive officer of Portage. “Obtaining this approval and commencing trading showcases our commitment to our investors and to the broader medical community through our unique approach to identifying and accelerating the development of the world’s most compelling immuno-oncology solutions.”

[the stigologist] 22/2/2021 23:25

Good to see PRTG ramp up the PR

$7m to $700m is going to make people sit up and take notice

[the stigologist] 20/2/2021 13:19

$100 translates to a Mkt Cap of c.$1bn which is below the average value of US quoted Clinical Stage Biotechs apparently

Portage is better than your average biotech IMO so I expect the Company to list at around $100 and go up from there.

Apparently someone has been in email contact with Jim Mellon re SALV and there are things going on. Much more promising talk that I'd have expected given SALV would be such a small part of Mellon's empire. Clearly has plans for it.

[bscuit] 20/2/2021 12:36

Yesterday was a rollercoaster day in share price terms.

For a UK company there is a requirement to lodge accounts – albeit less frequently than the Annual Return. It is odd that the link discloses nothing about annual accounts in lodged, though I have checked with a contact who was with a Cayman law firm with a IoM office and while I cannot remember the position for certain, he thinks it is likely that there is no requirement there to lodge accounts. So the financial position of the rump company is unknown, but holders should contact the RO. I no longer have shares.

[bobby.ifa] 20/2/2021 07:06

Stig, where does the $100 come from?

[the stigologist] 19/2/2021 19:02

Apparently there is a SALV Telegram group ?

[the stigologist] 18/2/2021 17:48

Document Type Description Date Received Price
IMAR Annual Return 11 Aug 2020 £ 2.00
NO-CSP Appointment/Change Of Nominated Officer 11 Aug 2020 £ 2.00

[the stigologist] 18/2/2021 15:59

SALV should relist or distribute remaining Portage stock in specie

[bscuit] 17/2/2021 22:39

Earlier today$38.

[the stigologist] 16/2/2021 18:50

PTGEF $30

Looks set for $100 on NASDAQ list